Nephrogenic Systemic Fibrosis News and Research

RSS
New high-performance, safe MRI contrast agent for 3D vascular mapping

New high-performance, safe MRI contrast agent for 3D vascular mapping

Novel MRI contrast agent shows strong potential as safer alternative to current products

Novel MRI contrast agent shows strong potential as safer alternative to current products

MGH researchers develop potential alternative to gadolinium-based MRI contrast agents

MGH researchers develop potential alternative to gadolinium-based MRI contrast agents

Researchers develop new iron oxide nanoparticles as contrast agent for MRI

Researchers develop new iron oxide nanoparticles as contrast agent for MRI

Non-contrast MRA can be viable diagnostic alternative for patients with chronic kidney disease

Non-contrast MRA can be viable diagnostic alternative for patients with chronic kidney disease

Study evaluates long-term safety of infants after maternal MRI exposure

Study evaluates long-term safety of infants after maternal MRI exposure

Animal study highlights major safety concern regarding use of MRI contrast agents in patients

Animal study highlights major safety concern regarding use of MRI contrast agents in patients

Study finds direct evidence of gadolinium deposition in neuronal tissues following contrast-enhanced MRI exams

Study finds direct evidence of gadolinium deposition in neuronal tissues following contrast-enhanced MRI exams

Dotarem gets FDA approval for use in patients undergoing CNS MRI

Dotarem gets FDA approval for use in patients undergoing CNS MRI

Small numbers of ANA- and RP-negative patients with systemic sclerosis

Small numbers of ANA- and RP-negative patients with systemic sclerosis

Jefferson researchers to investigate mechanisms involved in nephrogenic systemic fibrosis

Jefferson researchers to investigate mechanisms involved in nephrogenic systemic fibrosis

Restrictive gadolinium-based contrast agent guidelines help prevent nephrogenic systemic fibrosis

Restrictive gadolinium-based contrast agent guidelines help prevent nephrogenic systemic fibrosis

Gadavist approved by FDA for use in central nervous system MRI scans

Gadavist approved by FDA for use in central nervous system MRI scans

Bayer's gadobutrol injection for CNS imaging receives FDA Advisory Committee approval

Bayer's gadobutrol injection for CNS imaging receives FDA Advisory Committee approval

Toshiba announces new Vantage Titan HSR 1.5T MR with high slew rate gradients

Toshiba announces new Vantage Titan HSR 1.5T MR with high slew rate gradients

Toshiba announces multi-center trial to evaluate Time-SLIP Renal MR Angiography

Toshiba announces multi-center trial to evaluate Time-SLIP Renal MR Angiography

Jefferson researchers progress in understanding mechanism behind systemic fibrotic disorder

Jefferson researchers progress in understanding mechanism behind systemic fibrotic disorder

Lantheus Medical Imaging supports FDA action to ensure appropriate use of gadolinium-based contrast agents

Lantheus Medical Imaging supports FDA action to ensure appropriate use of gadolinium-based contrast agents

GBCAs carry new warnings on their labels about risk of NSF: FDA

GBCAs carry new warnings on their labels about risk of NSF: FDA

Toshiba announces 1,000th worldwide MR installation

Toshiba announces 1,000th worldwide MR installation